Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
AstraZeneca
McKinsey
Merck
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Palifermin - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for palifermin
Tradenames:1
Patents:44
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for palifermin

US Patents for palifermin

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15   See Pricing SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15   See Pricing ChemoCentryx, Inc. (Mountain View, CA) 2036-06-13 RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15   See Pricing Innovation Pharmaceuticals Inc. (Beverly, MA) 2031-05-16 RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15   See Pricing ChemoCentryx, Inc. (Mountain View, CA) 2036-04-04 RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15   See Pricing BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) 2031-04-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Supplementary Protection Certificates for palifermin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0016 France   See Pricing PRODUCT NAME: PALIFERMINE; REGISTRATION NO/DATE IN FRANCE: EU/1/05/314/001 DU 20051025; REGISTRATION NO/DATE AT EEC: EU/1/05/314/001 DU 20051025
0706563/01 Switzerland   See Pricing PRODUCT NAME: PALIFERMIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 57334 11.09.2006
C/GB06/004 United Kingdom   See Pricing PRODUCT NAME: PALIFERMIN; REGISTERED: UK EU/1/05/314/001 20051025
4/2006 Austria   See Pricing PRODUCT NAME: PALIFERMIN
2006 Austria   See Pricing PRODUCT NAME: PALIFERMIN; REGISTRATION NO/DATE: EU/1/05/314/001 20051025
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Harvard Business School
Baxter
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.